Isolated limb perfusion (ILP) with recombinant human tumor necrosis factor-α (rhTNF-α, or tasonermin) and melphalan is a highly effective treatment for soft tissue sarcoma and in-transit metastases of malignant melanoma of the extremities. This evidence concerns the gene TNF and melanoma.